(Q44326703)

2 December 2017

title

Effects of Cl2MDP-encapsulating liposomes in a murine model of Pseudomonas aeruginosa-induced sepsis (English)

1 reference

2 December 2017

0 references

Pseudomonas aeruginosa

1 reference

1 reference

Junichi Fujimoto

1

1 reference

2 December 2017

Jeanine P Wiener-Kronish

series ordinal

2

1 reference

2 December 2017

Satoru Hashimoto

series ordinal

3

1 reference

2 December 2017

Teiji Sawa

series ordinal

4

1 reference

2 December 2017

publication date

1 January 2002

1 reference

Journal of Liposome Research

2 December 2017

published in

1 reference

2 December 2017

volume

12

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

239-257

1 reference

The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Cytokines and anticytokines in the pathogenesis of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Ventilator-associated pneumonia due to Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Bacteremic nosocomial pneumonia. A 7-year experience in one institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Type III secretion machines: bacterial devices for protein delivery into host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

The liposome-mediated macrophage 'suicide' technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

Transient suppression of macrophage functions by liposome-encapsulated drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

A receptor for phosphatidylserine-specific clearance of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FLPR-120014760

21 January 2018

Identifiers

DOI

10.1081/LPR-120014760

1 reference

2 December 2017

1 reference